Found 19 matching trials
PE PREMIER CHINA CLINICAL TRIAL
NAPE PREMIER China: A Prospective, Multicenter Trial to Assess the Promus PRE...
Location
Multiple Locations
EVOLVE II QCA: A Prospective, Multicenter Trial to Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
PHASE3The purpose of this study is to evaluate 9 month angiographic and intravasc...
Location
The Prince Charles Hospital
A Clinical Trial to Confirm Safety & Effectiveness of the SYNERGY 4.50 mm and 5.00 mm Stent for Treatment of Atherosclerotic Lesion(s)
N/AEVOLVE 4.5/5.0 is a prospective, single-arm, multi-center observational (st...
Location
Yale New Haven Hospital
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
PHASE3The purpose of this study is to assess the safety and effectiveness of the ...
Location
Baptist Medical Center - Princeton
NG PROMUS Stent System for the Treatment of Atherosclerotic Coronary Lesions
NANG PROMUS: A Prospective, Multicenter Trial to Assess the NG PROMUS Everoli...
Location
Fremantle Hospital
SAMBA EU Femoropopliteal Trial
NAThe primary objective of this study is to evaluate the safety and performan...
Location
Herz Zentrum Bad Krozingen
A Safety and Efficacy Study of the Dynalink®-E Everolimus Eluting Peripheral Stent System
NAThe purpose of this first-in-man study is to evaluate the safety and perfor...
Location
Landeskrankenhaus Klagenfurt
Non-inferiority Study Comparing Firehawk Stent With Abbott Xience Family Stent (TARGET-AC)
NAPurpose The TARGET All comers trial is a prospective, multicenter, randomiz...
An Observational Safety Evaluation of Patients Treated With the NEVO™ Sirolimus-eluting Coronary Stent. (NEVO II)
PHASE3As a result of the implementation of Protocol Am3.0, the design and objecti...
Location
Erasmus MC - Thoraxcenter
The EVOLVE China Clinical Trial
NAThe purpose of this study is to assess the safety and effectiveness of the ...
Location
Beijing Affiliated Hospital of Armed Police Medical College